Publications dans lesquelles il/elle collabore avec LAURA PIQUERAS RUIZ (8)

2021

  1. Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 131-139

2018

  1. Coronary Serum Obtained After Myocardial Infarction Induces Angiogenesis and Microvascular Obstruction Repair. Role of Hypoxia-inducible Factor-1A

    Revista Espanola de Cardiologia, Vol. 71, Núm. 6, pp. 440-449

2017

  1. Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-elevation myocardial infarction

    Scientific Reports, Vol. 7, Núm. 1

2013

  1. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-ii

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 1, pp. 96-104

  2. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium

    Thorax, Vol. 68, Núm. 2, pp. 177-186

2010

  1. Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-γ upregulation

    Journal of Immunology, Vol. 185, Núm. 6, pp. 3718-3727

2007

  1. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 11, pp. 2370-2376

2002

  1. Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation

    British Journal of Pharmacology, Vol. 135, Núm. 8, pp. 1872-1881